Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 158, Issue 2, 2011, Pages 361-362

  Cascales, P A ^a   Gil, J ^a   Galindo, P J ^a   MacHado, F ^a   Frutos, I M Martinez ^a   Paricio, P Parrilla ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOMYCIN C; PACLITAXEL;

ABDOMINAL PAIN; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER; CYTOREDUCTIVE SURGERY; HUMAN; HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; LETTER; OVARY CARCINOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; TOXICITY;

EID: 80053583541     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.04.036     Document Type: Letter

References (21)

1. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
2. P.H. Sugarbaker Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal Ann Surg Oncol 17 2010 1710 1712
3. V.J. Verwaal, S. Bruin, and H. Boot 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 September (9) 2008 2426 2432
4. D.S. Alberts, P.Y. Liu, and E.V. Hannigan Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 1996 1950 1955 (Pubitemid 26428219)
5. M. Markman, B.N. Bundy, and D.S. Alberts Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 2001 1001 1007 (Pubitemid 32176274)
6. D.K. Armstrong, B. Bundy, and L. Wenzel Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43 (Pubitemid 43048949)
7. E.L. Trimble, and M.C. Christian Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma Gynecol Oncol 100 2006 3 4 (Pubitemid 41815040)
8. T.C. Chua, G. Robertson, and W. Liauw Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1644
9. T.C. Chua, W. Liauw, and G. Robertson Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis Gynecol Oncol 114 2009 137 139
10. http://clinicaltrials.gov/ct2/show/NCT00426257.
11. F. Roviello, E. Pinto, and G. Corso Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer J Surg Oncol 102 2010 663 670
12. M.C. Lim, S. Kang, and J. Choi Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study Ann Surg Oncol 16 2009 993 1000
13. M.J. Pavlov, P.A. Kovacevic, and M.S. Ceranic Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience Eur J Surg Oncol 35 2009 1186 1191
14. E. Guardiola, D. Delroeux, and B. Heyd Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World J Surg Oncol 9 2009 14
15. A. Di Giorgio, E. Naticchioni, and D. Biacchi Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer Cancer 113 2008 315 325
16. J.H. Bae, J.M. Lee, and K.S. Ryu Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery Gynecol Oncol 106 2007 193 200 (Pubitemid 46898592)
17. E. Cotte, O. Glehen, and F. Mohamed Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World J Surg 31 2007 1813 1820 (Pubitemid 47283201)
18. S. Rufián, F.C. Muñoz-Casares, and J. Briceño Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer J Surg Oncol 94 2006 316 324 (Pubitemid 44330855)
19. F. Raspagliesi, S. Kusamura, and J.C. Campos Torres Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan Eur J Surg Oncol 32 2006 671 675 (Pubitemid 44063998)
20. K.S. Ryu, J.H. Kim, and H.S. Ko Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer Gynecol Oncol 94 2004 325 332 (Pubitemid 39024534)
21. C. Zanon, R. Clara, and I. Chiappino Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer World J Surg 28 2004 1040 1045 (Pubitemid 40109891)